Overview of Biomotum Inc.
At Biomotum, we’re building intelligent and intuitive wearable devices to address the rapidly increasing number of people with poor health due to difficulty walking. Our products combine innovative assistive technology with AI-enabled coaching to deliver life-changing improvements in walking.
THE OPPORTUNITY
- 38M people: neurologic conditions that impair walking
- Treatment: physical therapy (PT) & assistive devices
- Challenges: inefficient PT & ineffective assistive devices
- Only 25% achieve their walking function goals
- Providers & patients are demanding better outcomes
OUR SOLUTION
- Accessible: low-cost, lightweight, simple to use
- Proven1 to improve walking function
- Dual-function: daily assistance & gait training
- Broad application: neuro, healthy aging, ortho
- Smart: adaptive, tracks function, RTM-enabled
OUR APPROACH
- Business model: B2B2C, Hardware & SaaS
- Revenue: $10M in 2028
- Fundraising to date: $3M seed; $7.0M grants
- Regulatory: FDA class II 510(k), path to clearance
- Reimbursement: accelerated via Breakthrough
- IP: Exclusive license, 9 patents, 25+ pubs
- Beachhead market: Cerebral Palsy
- Clinical launch in 2026: Canada & Australia
Our Ask
We are seeking partners who can help us launch our active bracing solutions for individuals who have difficulty walking. Partnerships that provide financial resources to assist with commercialization efforts and/or clinical trials research are our top priorities.